Although C-ANCA has a high specificity 90–95% [10,11], it has been reported in patients with infections such as HIV, CMV Mycobacterium avium-intercellulare, invasive amebiasis, Bartonella Henessae, and Malaria. Here, PRTN3 is linked to infection.